Joshua Eckelberry is a venture capitalist and healthcare strategist. He earned his Bachelor of Science in Biochemistry from East Tennessee State University, his Master of Business Administration in Healthcare Administration, and attended the Quillen College of Medicine. Joshua is a Partner at Solas BioVentures, where he focuses on advancing innovations that create leveraged change and lasting good across healthcare. He serves on the Boards of IO Urology and Eir Systems and as a Board Observer for Francis Medical, Vektor Medical, and Intershunt Technologies. His work integrates scientific insight, operational rigor, and a mission driven approach to improving patient lives and system wide outcomes.​